Oncotarget

Research Papers:

HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma

Laura Pellegrini, Jiaming Xue, David Larson, Sandra Pastorino, Sandro Jube, Kelly H. Forest, Zeyana Salim Saad-Jube, Andrea Napolitano, Ian Pagano, Vishal S. Negi, Marco E. Bianchi, Paul Morris, Harvey I. Pass, Giovanni Gaudino, Michele Carbone, Haining Yang _

PDF |  HTML  |  Supplementary Files  |  Author Information  |  Order a Reprint

Oncotarget. 2017; 8:22649-22661. doi: 10.18632/oncotarget.15152

Metrics: PDF 299 views  |   HTML 111 views  |   ?  


Abstract

Laura Pellegrini1, Jiaming Xue1,3, David Larson1, Sandra Pastorino1, Sandro Jube2, Kelly H. Forest3, Zeyana Salim Saad-Jube4, Andrea Napolitano1,5, Ian Pagano1, Vishal S. Negi5, Marco E. Bianchi6, Paul Morris7, Harvey I. Pass8, Giovanni Gaudino1, Michele Carbone1, Haining Yang1

1University of Hawai'i Cancer Center, University of Hawai'i at Manoa, Honolulu, HI, USA

2University of Hawai'i at Manoa, Department of Cell and Molecular Biology, John A. Burns School of Medicine, Honolulu, HI, USA

3Leeward Community College, Mathematics and Sciences Division, University of Hawai'i System, Pearl City, HI, USA

4University of Hawai'i at Manoa, Myron B. Thompson School of Social Work, Office of Public Health and Center on Aging, Honolulu, HI, USA

5University of Hawai'i at Manoa, Department of Molecular Biosciences and Bioengineering, Honolulu, HI, USA

6San Raffaele University and Research Institute, Milan, Italy

7Department of Thoracic Surgery, Queen's Medical Center, Honolulu, HI, USA

8New York University School of Medicine, Department of Cardiothoracic Surgery, New York, NY, USA

Correspondence to:

Haining Yang, email: hyang@cc.hawaii.edu

Michele Carbone, email: mcarbone@cc.hawaii.edu

Keywords: HMGB1, RAGE, ethyl pyruvate, mesothelioma, therapeutic

Received: June 30, 2016     Accepted: January 23, 2017     Published: February 07, 2017

ABSTRACT

Human malignant mesothelioma (MM) is an aggressive cancer linked to asbestos and erionite exposure. We previously reported that High-Mobility Group Box-1 protein (HMGB1), a prototypic damage-associated molecular pattern, drives MM development and sustains MM progression. Moreover, we demonstrated that targeting HMGB1 inhibited MM cell growth and motility in vitro, reduced tumor growth in vivo, and prolonged survival of MM-bearing mice. Ethyl pyruvate (EP), the ethyl ester of pyruvic acid, has been shown to be an effective HMGB1 inhibitor in inflammation-related diseases and several cancers. Here, we studied the effect of EP on the malignant phenotype of MM cells in tissue culture and on tumor growth in vivo using an orthotopic MM xenograft model. We found that EP impairs HMGB1 secretion by MM cells leading to reduced RAGE expression and NF-κB activation. As a consequence, EP impaired cell motility, cell proliferation, and anchorage-independent growth of MM cells. Moreover, EP reduced HMGB1 serum levels in mice and inhibited the growth of MM xenografts.

Our results indicate that EP effectively hampers the malignant phenotype of MM, offering a novel potential therapeutic approach to patients afflicted with this dismal disease.

Author Information

Laura Pellegrini

Jiaming Xue

David Larson

Sandra Pastorino

Sandro Jube

Kelly H. Forest

Zeyana Salim Saad-Jube

Andrea Napolitano

Ian Pagano

Vishal S. Negi

Marco E. Bianchi

Paul Morris

Harvey I. Pass

Giovanni Gaudino

Michele Carbone

Haining Yang
Primary Contact  _


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 15152